Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Transpl Infect Dis ; 23(4): e13606, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1146666


Severe acute respiratory syndrome coronavirus 2 can lead to life-threatening coronavirus disease 2019 (COVID-19) infections in patients with hematologic malignancies, particularly among hematopoietic cell transplant (HCT) recipients. We describe two patients with COVID-19 during the pre-engraftment period after HCT and review previous reports of COVID-19 in HCT recipients. Because of significant mortality from COVID-19, primarily after allogeneic HCT, early, preemptive, and optimal directed therapy may improve outcomes and reduce the mortality rate but still needs to be established in clinical trials.

COVID-19 , Hematopoietic Stem Cell Transplantation , Immune Reconstitution , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , SARS-CoV-2 , Transplant Recipients
Mediterr J Hematol Infect Dis ; 12(1): e2020044, 2020.
Article in English | MEDLINE | ID: covidwho-854283


The emergence and spread of 2019 novel coronavirus have led to an unprecedented public health crisis around the globe, threatening the lives of millions of people. We report a severe case of COVID-19 in a patient with chronic lymphocytic leukemia and describe primarily the clinical presentation and the challenges encountered in the COVID-19 diagnosis, treatment, and specimens sampling pitfalls. This case highlights the importance of a comprehensive diagnostic approach of pneumonia in immunocompromised hosts, including timely and safe bronchoscopy, because of the broad differential diagnosis, more challenging with the current outbreak of COVID-19.